Kids make the cost issue even worse. It may be fairly easy to train an EMT or an adult with a deadly allergy to use a syringe, but a huge number of people with EpiPen-worthy allergies are children, and:

A) Teaching a small child to use a syringe falls somewhere between not easy and impossible.

B) If a child needs Epinephrine, someone else — possibly someone untrained in the use of EpiPens, let alone syringes — will have to administer the Epinephrine to him.

C) Even when adults need Epinephrine, it may be more practical for a third party to administer the injection. It’s a bad idea to rely on this third party having been trained to administer injections.

Given those issues, the company that sells EpiPens is acting atrociously.